In 2011, AstraZeneca ($AZN) jettisoned about 1,200 employees when it shuttered its R&D shop near Nottingham, U.K., but now the city is home to 22 life sciences startups launched by the drugmaker's former workers. Incubated by two universities and a local trade group, Nottingham's burgeoning biotech scene includes fast-growing CROs and consulting groups, mostly made up of ex-AZ researchers. Story